TFOS lifestyle: Impact of societal challenges on the ocular surface

F Stapleton, JC Abad, S Barabino, A Burnett, G Iyer… - The Ocular Surface, 2023 - Elsevier
Societal factors associated with ocular surface diseases were mapped using a framework to
characterize the relationship between the individual, their health and environment. The …

TFOS Lifestyle: impact of nutrition on the ocular surface

M Markoulli, S Ahmad, J Arcot, R Arita… - The ocular …, 2023 - Elsevier
Nutrients, required by human bodies to perform life-sustaining functions, are obtained from
the diet. They are broadly classified into macronutrients (carbohydrates, lipids, and proteins) …

TFOS Lifestyle: Impact of contact lenses on the ocular surface

L Jones, N Efron, K Bandamwar, M Barnett, DS Jacobs… - The ocular …, 2023 - Elsevier
Several lifestyle choices made by contact lens wearers can have adverse consequences on
ocular health. These include being non-adherent to contact lens care, sleeping in lenses, ill …

BCLA CLEAR-Anatomy and physiology of the anterior eye

LE Downie, S Bandlitz, JPG Bergmanson… - Contact Lens and …, 2021 - Elsevier
A key element of contact lens practice involves clinical evaluation of anterior eye health,
including the cornea and limbus, conjunctiva and sclera, eyelids and eyelashes, lacrimal …

[HTML][HTML] Lotilaner ophthalmic solution 0.25% for Demodex blepharitis: Randomized, vehicle-controlled, multicenter, phase 3 trial (saturn-2)

IB Gaddie, ED Donnenfeld, P Karpecki, P Vollmer… - Ophthalmology, 2023 - Elsevier
Purpose To evaluate the safety and efficacy of lotilaner ophthalmic solution 0.25%
compared with vehicle for the treatment of Demodex blepharitis. Design Prospective …

Clinical diagnosis and management of Demodex blepharitis: the Demodex Expert Panel on Treatment and Eyelid Health (DEPTH)

BD Ayres, E Donnenfeld, M Farid, IB Gaddie, PK Gupta… - Eye, 2023 - nature.com
Background Twelve ocular surface disease experts convened to achieve consensus about
Demodex blepharitis (DB) using a modified Delphi panel process. Methods Online surveys …

Lotilaner ophthalmic solution, 0.25%, for the treatment of demodex blepharitis: results of a prospective, randomized, vehicle-controlled, double-masked, pivotal trial …

E Yeu, DL Wirta, P Karpecki, SN Baba, M Holdbrook… - Cornea, 2023 - journals.lww.com
Purpose: The purpose of this study was to evaluate the safety and efficacy of lotilaner
ophthalmic solution, 0.25%, compared with vehicle for the treatment of Demodex blepharitis …

Demodex blepharitis: A comprehensive review of the disease, current management, and emerging therapies

MK Rhee, E Yeu, M Barnett, CJ Rapuano… - Eye & Contact …, 2023 - journals.lww.com
Demodex blepharitis is a common disease of the eyelid, affecting approximately 25 million
Americans. This article reviews what is known about the mechanisms and impact of …

The Prevalence of Demodex Blepharitis in US Eye Care Clinic Patients as Determined by Collarettes: A Pathognomonic Sign

W Trattler, P Karpecki, Y Rapoport, E Sadri… - Clinical …, 2022 - Taylor & Francis
Purpose To evaluate the prevalence of Demodex blepharitis by its pathognomonic sign,
collarettes, in patients presenting for any reason to eye care clinics in the United States …

[HTML][HTML] Safety and efficacy of lotilaner ophthalmic solution, 0.25% for the treatment of blepharitis due to demodex infestation: a randomized, controlled, double …

R Gonzalez-Salinas, P Karpecki, E Yeu… - Contact Lens and …, 2022 - Elsevier
Purpose To evaluate the safety and efficacy of lotilaner ophthalmic solution, 0.25% for the
treatment of blepharitis due to Demodex infestation compared to vehicle control. Methods In …